We create value.
aXichem is an innovative biotechnology company specialising in development of natural analogue ingredients.
Read more

We create value.

Aktiedata

AXICHEM A
(AXIC A)
High
44.8
Low
40.2
Volume
19937
Turnover
844670.7
Read more
March 31, 2020 16:55:19
Financial Reports
Financial Reports
No results
Read more

Financial Calendar

Year-end report 2019 - 27 February 2020
Interim report 1/2020 - 14 May 2020
Annual report 2019 - 5 May 2020
Annual General Meeting 2019 - 26 May 2020
Interim report 2/2020 - 21 August 2020
Interim report 3/2020 - 12 November 2020

All Press Releases
Regulatory Press Releases
February 27, 2020
aXichem AB (publ), Bokslutskommuniké januari – december 2019
aXichems utveckling under 2019 samt under fjärde kvartalet 2019 2019-01-01 Read the article here
January 27, 2020
aXichem levererar sju ton aXiphen® till distributören CHR. Olesen
aXichem AB (publ), som utvecklar och marknadsför naturanaloga industrikemikalier, har levererat Read the article here
Read more

Company description

We draw from the genius of nature and respect nature in return.

Corporate Governance

January 01, 1970
January 01, 1970

Meetings Archive

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Fullmaktsformulär 2019
pdf 34.75 KB
Kallelse till årsstämma i aXichem 2019
pdf 86.71 KB
Protokoll stämma 2018
pdf 775.25 KB
Årsredovisning 2017
pdf 6.48 MB
Fullmaktsformulär
pdf 206.00 KB
Kallelse stämma 2018
pdf 62.98 KB
Kallelse stämma 2017
pdf 219.08 KB
Fullmaktsformulär
pdf 29.26 KB
Årsredovisning 2016 för aXichem AB
pdf 6.64 MB
Fullmaktsformulär
pdf 328.53 KB
Styrelsens förslag till beslut om bemyndigande
pdf 21.17 KB
Kallelse stämma 2016
pdf 52.19 KB
Kallelse stämma 2015
pdf 101.92 KB
Kallelse stämma 2014
pdf 148.06 KB
Kommuniké stämma 2013
pdf 68.63 KB
Kallelse stämma 2013
pdf 178.91 KB
Kommuniké stämma 2012
pdf 330.61 KB
Kallelse stämma 2012
pdf 324.54 KB
Kommuniké stämma 2011
pdf 175.42 KB
Kallelse stämma 2011
pdf 270.76 KB
Kommuniké stämma 2010
pdf 38.08 KB
Kallelse stämma 2010
pdf 49.63 KB
Kommuniké stämma 2009
pdf 51.81 KB
Kallelse stämma 2009
pdf 66.03 KB

Financial Advisor and Certified Advisor

Redeye AB
Box 7141
103 87 Stockholm
08-545 013 30
www.redeye.se

 

Eddie Palmgren
+46 736 515 24

Corporate Governance

We create value.

Investor Structure

Largest owners as of 31 March 2019 aXichem’s ten largest owners according to the shareholders’ register kept by Euroclear

 

Name No. of shares Participating interest (%)
Manakin Ltd 1 915 391 12,02
LMK -bolagen 1 686 697 10,59
Försäkringsaktiebolaget Avanza Pension   859 499  5,40
Danica Pension   806 784  5,06
Nordnet Pensionsförsäkring AB    619 590  3,89
Redoterm AB   365 501  2,29
IBKR Financial Service AG   336 343  2,11
SEB Life International Ass Co Ltd   302 223  1,90
Hans Sköld   289 077  1,81
Per Vasilis   281 047  1,76

 

Investor enquiries

Subscribe to information from Axichem via First North.
Subscription Feed*

Language*

Name Surname*

E-mail*

Company Name

SMS (+46709123456)